Covalently Binding Adenosine A3 Receptor Agonist ICBM Irreversibly Reduces Voltage-Gated Ca2+ Currents in Dorsal Root Ganglion Neurons

Federica Cherchi(University of Florence), Elisabetta Coppi(University of Florence)

Purinergic Signalling

March 15, 2023

10.1007/s11302-023-09929-y

Cited by 4

Related Papers

MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats

|Neuropharmacology|2024|4

8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia

|Bioorganic Chemistry|2025|0

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist

|Neuropharmacology|2025|0

Protection From Demyelination by the Novel Adenosine Dual <scp> A <sub>2A</sub> </scp> / <scp> A <sub>2B</sub> </scp> Receptor Antagonist <scp>P626</scp> in <scp>EAE</scp> and Cultured Oligodendrocyte Precursor Cells

|Journal of Cellular and Molecular Medicine|2025|0